NeuroSense Therapeutics jobs and careers
Herzliya, Tel Aviv District, Israel
About NeuroSense Therapeutics
NeuroSense Therapeutics is a clinical stage drug development company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.
Founded in 2017 by Alon Ben-Noon.
- Founded
- 2017
- Employees
- 11 to 50
- Total funding
- $10.1M
- Headquarters
- Herzliya
Leadership
The top of NeuroSense Therapeutics's org chart, with how many people report into each leader.
Alon Ben-Noon
Co-Founder & CEO
16 reports
Oron Yacoby-Zeevi
Chief Scientific Officer
4 reports
Diana Shtossel
Head of Regulatory Affairs
2 reports
Keren Pushett
Head of HR
1 report
Racheli Gueta
Director Clinical Development
1 report
Hagit Binder
General Manager
1 report
Niva Russek-Blum
Chief Technology Officer
Or Eisenberg
Chief Financial Officer
Board
Mark Leuchtenberger
Chairman, Board of Directors
Cary Claiborne
Member Board Of Directors; Audit Committee Chair
Yossi Gilgun-Sherki
Scientific Advisory Board (SAB) Member
Jeremy Shefner
Scientific Advisor
Revital Mandil-Levin
Advisor
Jeffrey Rosenfeld
Scientific Advisory Board Member
Jobs at NeuroSense Therapeutics
No open positions right now. Explore more companies on TheJobsMap.